A row between Gilead Sciences and ViiV Healthcare over HIV drug ads has escalated. With ViiV declining to participate in a self-regulatory process, the National Advertising Division (NAD) has referred ...
July 10 (Reuters) - British Drugmaker GlaxoSmithKline Plc on Wednesday said its two-drug HIV regimen Dovato was successful in suppressing the AIDS-causing virus in patients for 48 weeks at similar ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback